I used to post years ago on this site, but took a break for a few years, and stopped paying close attention to the hair loss world.
Back then, people were talking about Intercytex, Gho, Bazan, Aderans…
So now, I’ve tried to catch up on the state of things, and put a little bit of commentary. Let me know if you think there are any inaccuracies, and please fill out any holes (for example, numbers in terms of Histogen and Replicel trials).
Aderans - Gone
Gho - Seems to now be performing some sort of “donor doubling” procedure. Hasn’t proved it, despite a few years now, and whether or not it works seems to still be up for much debate.
Histogen - Released results showing that they could grow hair in a Phase I/II trial, though the results didn’t seem very spectacular. Were involved in a sort of reverse merger recently that didn’t go through.
Replicel - Also released results showing some growth, though the numbers seem disappointing, more so than Histogen, though they seemed to talk up those results.
Follica - Seems to be based on wounding and growth factors. Not sure what their results have been so far. Recently hyped in a few media articles.
Nigam - Not sure what to make of this one. Reminds me a lot of Bazan (which left a bad taste in our mouths, many years ago). So far, some evidence of deceit, and no proof, and a lot of controversy. Hopefully we’ll know more in a few months.
Pilox II - Now this one is intriguing. Very good (and real looking) photos appear on a hair loss forum. Long term posters on that forum manage to apparently get into “trials” (though we don’t really know what’s going on). Suddenly, the whole thread is deleted, and no further talk about Pilox is allowed. I wonder if this has to do with proprietary photos having been posted without permission. Anyway, mysterious, but perhaps promising (with the usual heavy grain of salt).
Pilofocus - Not going to be a cure, but if it pans out, could revolutionize transplants.
CB-01-03 - Seems to be a topical inhibitor of DHT, more efficacious than Finasteride. Still in trials and not due for a release for a few years.